Skip to main content
OpenTrials

Clinical trial condition

Noonan Syndrome

Explore clinical trials studying Noonan Syndrome. Study availability and eligibility vary by location and protocol.

38 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Noonan Syndrome trial results

Completed

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Washington University School of Medicine Seattle, Washington, United States
View Trial Details
Completed

A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China

NCT04121286

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical Collage Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Completed

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

NCT03518554

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

NCT03565003

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chinese PLA Central Hospital Beijing, Beijing Municipality, China
View Trial Details
Completed

A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC

NCT04959981

Conditions
Advanced Non-squamous Non-small-cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
Locations
  • City of Hope Duarte, California, United States
  • UC Irvine, Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Los Angeles Santa Monica, California, United States
  • University of Colorado Aurora, Colorado, United States
View Trial Details
Completed

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

NCT03989115

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +61 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 24 locations
View Trial Details

Related conditions